Our Goals
- We provide education, resources, and support to kidney cancer patients and caregivers
- We identify patients’ and researchers’ unmet needs
- We engage and educate policymakers on the urgency of kidney cancer research funding
- We urge Congress to fund kidney cancer research
- We increase CDMRP Kidney Cancer Research Program and NIH funding through advocacy
- We provide direct funding to promising ideas
- We propel collaboration and progress in kidney cancer research (Kidney Cancer Research Summit)
- We grow the community of kidney cancer researchers
- We support the development of new treatments by educating patients on trial access and enrollment
- We identify new unmet needs, set new goals, and keep working
Our Mission
Our mission is to accelerate cures for kidney cancer. We engage in patient advocacy and power research by supporting government and industry research funding, facilitating research collaborations, and offering direct financial support for clinical and laboratory researchers with promising ideas. Together, we can find the cure.
NEWLY DIAGNOSED?
You’re not alone. We’ve put together a Patient Resource Center to help you navigate a new diagnosis and beyond. Learn about kidney cancer, various treatment options, patient education events, and how to live well with cancer.
BUILD A CARE TEAM
Join Our Grassroots Army
What are we advocating for?
Awareness? Funding? Research? Cures?
#WCRM is meeting again for first time in the new year, ready to present our kidney cancer research at #GU22 next month whether virtually or in person @DanaFarber_GU
1/ Happy to share with you our analysis of PROs/QOLs from the CheckMate-9ER trial of Nivo+Cabo vs. Sun. in patients with metastatic #RCC, just published in @TheLancetOncol
@CellaDavid ...@motzermd @apolo_andrea @DanaFarber_GU @OncoAlert
https://t.co/KkPl90C6t2
Excited to join the Beijing anti-cancer association’s Beijing GU oncology updates conference w/ good friends @neerajaiims @PGrivasMDPhD & me giving the keynotes in #prostatecancer, ...#bladdercancer & #kidneycancer this evening. A true privilege to visit my hometown virtually.
Congratulations, @BraunMDPhD! Look forward to watching your great work unfold at @YaleCancer @YaleMed 👏👏👏
Officially settling in here @YaleCancer @YaleMed, and I am grateful for the warm welcome!
If you are interested in cancer immunotherapy, translational research, genomics, or kidney cancer, please contact me ([email protected]). We are hiring at all levels (postgrad, MS, PhD)!
Truly honored to be in this lineup of great people working to #acceleratecures for #kidneycancer and #GUcancers!
Thank you to @weoncologists and the @OncoAlert #OncoAlertColloquium for ...allowing us to share about KidneyCAN’s advocacy and #KCRS.
Thanks for Joining us for DAY1⃣of our #OncoAlertColloquium 🚨
🙏 @DrChoueiri @apolo_andrea @neerajaiims @piet_ost @seanmmcbride @kidneycan @SIOGorg @ravikanesvaran & @nicolobattisti
This Video📺is NOW Available‼️
JUST CLICK
https://www.youtube.com/watch?v=razFoXCU03k
or http://www.OncoAlert360.com
@TiansterZhang @PGrivasMDPhD @DrChoueiri @Daniel_J_George @utswcancer @UTSWHemeOnc @montypal @Huntsman_GU @fredhutch @Zihai @OncoAlert @HHammersMD @KCA_Journal @kidneycan @IKCCorg @umangtalking ...@nsayeghmd @TripNish Personalizing medicine in metastatic #kidneycancer : ongoing approaches and trials. Excellent overview by @TiansterZhang at Beijing GU oncology update.
@TiansterZhang @PGrivasMDPhD @DrChoueiri @Daniel_J_George @utswcancer @UTSWHemeOnc @montypal @Huntsman_GU @fredhutch @Zihai Always enjoy the wonderful talks by @TiansterZhang 👉first line ...metastatic RCC #kidneycancer trials, summary and future directions. @PGrivasMDPhD This one at the Beijing GU oncology conference. Mentioning @DrChoueiri @OncoAlert
Critical findings from @DrChoueiri et al, illustrating the importance of protecting #cancer patients from #COVID19.
ACS strongly endorses the recommendation for vaccination of close ...contacts, boosters, social distancing, & masking. @AmericanCancer https://t.co/zGuePbjpUZ
Latest News
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Program (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.
